Amryt Granted Orphan Drug Designation by the FDA for AP103
Amryt Granted Orphan Drug Designation by the FDA for AP103 DUBLIN, Ireland, and Boston MA, December 23, 2020, Amryt (Nasdaq:...
Amryt Granted Orphan Drug Designation by the FDA for AP103 DUBLIN, Ireland, and Boston MA, December 23, 2020, Amryt (Nasdaq:...
VANCOUVER, Dec. 22, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF /...
COPENHAGEN, Denmark, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company developing AI-driven immunotherapies, announces today the...
Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs1,2,3Treatment with...
Will Trade on the Nasdaq Global Market Under Ticker “GBS”NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (the...
Annual Meeting to be adjourned solely with respect to Item 2, and Item 2 to be modified to decrease the...
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new...
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of a new...
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that an Emergency Use...
Met primary endpoint with robust statistical significanceShowed efficacy on both hyperactivity/impulsivity and inattention subscales with statistical significanceShowed statistically significant onset...
Improves liquidity and operating flexibilitySignificantly reduces borrowing costsSupports ongoing transformation to profitable growth platformHOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE)...
CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual and...
CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual...
LEXINGTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing...
Lille (France), Cambridge (Massachusetts, United States), December 22, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated...
CAMBRIDGE, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) today announced that the U.S. Food and...
SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of...
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
REDWOOD CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ: ALLK), a biotechnology company developing lirentelimab (AK002) for...
JERSEY, Channel Islands, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced...